Fennec Ebitda vs Income Tax Expense Analysis
FENC Stock | USD 7.31 0.27 3.84% |
Fennec Pharmaceuticals financial indicator trend analysis is much more than just examining Fennec Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fennec Pharmaceuticals is a good investment. Please check the relationship between Fennec Pharmaceuticals Ebitda and its Income Tax Expense accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.
Ebitda vs Income Tax Expense
Ebitda vs Income Tax Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fennec Pharmaceuticals Ebitda account and Income Tax Expense. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Fennec Pharmaceuticals' Ebitda and Income Tax Expense is -0.03. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Fennec Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Fennec Pharmaceuticals' Ebitda and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Fennec Pharmaceuticals are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Ebitda i.e., Fennec Pharmaceuticals' Ebitda and Income Tax Expense go up and down completely randomly.
Correlation Coefficient | -0.03 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Ebitda
Income Tax Expense
Most indicators from Fennec Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fennec Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.At present, Fennec Pharmaceuticals' Enterprise Value is projected to increase significantly based on the last few years of reporting.
Fennec Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Fennec Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fennec Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.1M | 31.4M | 22.4M | 26.9M | 26.7M | 16.1M | |
Other Current Liab | 659K | 776K | 877K | 2.2M | 3.8M | 2.1M | |
Total Current Liabilities | 2.3M | 2.3M | 1.7M | 4.6M | 7.5M | 7.9M | |
Total Stockholder Equity | 11.9M | 29.1M | 15.8M | (2.6M) | (11.6M) | (11.0M) | |
Net Tangible Assets | 11.9M | 29.1M | 15.8M | (2.6M) | (3.0M) | (2.8M) | |
Net Debt | (13.7M) | (30.3M) | (16.1M) | 1.1M | 16.4M | 17.2M | |
Retained Earnings | (144.0M) | (162.1M) | (179.5M) | (203.2M) | (218.1M) | (207.2M) | |
Accounts Payable | 1.6M | 1.6M | 777K | 2.4M | 3.8M | 3.9M | |
Cash | 13.7M | 30.3M | 21.1M | 23.8M | 13.2M | 11.0M | |
Other Assets | 262K | 1.1M | 27K | 211K | (0.3) | (0.28) | |
Cash And Short Term Investments | 13.7M | 30.3M | 21.1M | 23.8M | 13.2M | 11.7M | |
Retained Earnings Total Equity | (131.3M) | (144.0M) | (162.1M) | (179.5M) | (161.5M) | (153.5M) | |
Common Stock Shares Outstanding | 19.9M | 23.7M | 26.0M | 26.3M | 26.6M | 27.9M | |
Liabilities And Stockholders Equity | 14.1M | 31.4M | 22.4M | 26.9M | 26.7M | 16.1M | |
Non Current Liabilities Total | 1.6M | 1.6M | 5.0M | 24.9M | 30.8M | 32.3M | |
Other Current Assets | 234K | 276K | 253K | 63K | 2.6M | 2.7M | |
Other Stockholder Equity | 48.3M | 49.2M | 53.2M | 56.8M | 61.8M | 38.1M | |
Total Liab | 2.3M | 2.3M | 6.6M | 29.5M | 38.3M | 40.2M | |
Total Current Assets | 13.9M | 31.4M | 22.4M | 26.7M | 26.7M | 28.1M | |
Capital Surpluse | 44.9M | 48.3M | 49.2M | 53.2M | 61.2M | 49.4M | |
Net Invested Capital | 11.9M | 29.1M | 20.8M | 22.3M | 19.3M | 17.3M | |
Net Working Capital | 11.6M | 29.1M | 20.7M | 22.1M | 19.3M | 17.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 1.684 | Quarterly Revenue Growth 14.132 | Return On Assets 0.0857 | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.